Assessment of toxicological potential of sodium carboxymethyl beta-glucan, a novel beta-glucan
In this experimental work, sodium carboxymethyl beta-glucan (CMBG), a chemically altered beta-glucan, is evaluated for mutagenicity and sub-acute oral toxicity. Specifically, the tested material was CM-Glucan Nu, a food grade powder ≥90% CMBG derived from Saccharomyces cerevisiae. A bacterial revers...
Uložené v:
| Vydané v: | Food and chemical toxicology Ročník 152; s. 112226 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
Elsevier Ltd
01.06.2021
|
| Predmet: | |
| ISSN: | 0278-6915, 1873-6351, 1873-6351 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Shrnutí: | In this experimental work, sodium carboxymethyl beta-glucan (CMBG), a chemically altered beta-glucan, is evaluated for mutagenicity and sub-acute oral toxicity. Specifically, the tested material was CM-Glucan Nu, a food grade powder ≥90% CMBG derived from Saccharomyces cerevisiae. A bacterial reverse mutation test was performed and resulted in no mutagenicity. A 28-day, repeated-dose, oral (gavage) toxicity test on rats was performed at dose levels of 0, 500, 1000, and 2000 mg/kg bw/day. No mortality, target organs or other treatment related effects were observed. The no observed adverse effect level (NOAEL) was 2000 mg/kg bw/day, the highest dose tested, for both male and female Han:WIST rats.
•Sodium carboxymethyl beta-glucan is without mutagenicity under the experimental conditions applied.•The no observed adverse effect level of an OECD, 28-day toxicological study was 2000 mg/kg bw/day.•The findings contribute to the safety evaluation of carboxymethyl beta-glucan. |
|---|---|
| Bibliografia: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ISSN: | 0278-6915 1873-6351 1873-6351 |
| DOI: | 10.1016/j.fct.2021.112226 |